Theoretical studies of Alzheimer's disease drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine (GTS-21) and its derivatives.

Theoretical and molecular modeling studies have been conducted for understanding the details of how 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (GTS-21) and its metabolism derivatives bind with the receptor of alpha7 nicotinic acetylcholine dimer. Good accordance with experimental results has been achieved. It was found that the van der Waals repulsion makes the dominant contribution to the binding energy. GTS-21 and its metabolites are apparently too large for the binding sites of the alpha7 dimer. To improve the effectiveness of the drug, a possible approach is to reduce its volume while maintaining the presence of the active groups. Our studies, in combination with experimental studies, will lead to a promising basis for practical drug design against Alzheimer's disease.

[1]  William R Kem,et al.  The brain α7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21) , 2000, Behavioural Brain Research.

[2]  Kuo-Chen Chou.  Insights from modeling three-dimensional structures of the human potassium and sodium channels. , 2004, Journal of proteome research.

[3]  S. Rogers,et al.  A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. , 1992, Molecular pharmacology.

[4]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[5]  Kuo-Chen Chou,et al.  Modeling the tertiary structure of human cathepsin-E. , 2005, Biochemical and biophysical research communications.

[6]  R. Freedman,et al.  Selective α7-nicotinic agonists normalize inhibition of auditory response in DBA mice , 1998, Psychopharmacology.

[7]  K D Watenpaugh,et al.  A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator. , 1999, Biochemical and biophysical research communications.

[8]  Kuo-Chen Chou,et al.  Coupling interaction between thromboxane A2 receptor and alpha-13 subunit of guanine nucleotide-binding protein. , 2005, Journal of proteome research.

[9]  A. C. Collins,et al.  Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. , 1982, Molecular pharmacology.

[10]  K. Chou.  Structural bioinformatics and its impact to biomedical science. , 2004, Current medicinal chemistry.

[11]  J. Changeux,et al.  Brain nicotinic receptors: structure and regulation, role in learning and reinforcement 1 Published on the World Wide Web on 24 October 1997. 1 , 1998, Brain Research Reviews.

[12]  C. Gotti,et al.  Human neuronal nicotinic receptors , 1997, Progress in Neurobiology.

[13]  J. Changeux,et al.  Distribution and Pharmacology of α6-Containing Nicotinic Acetylcholine Receptors Analyzed with Mutant Mice , 2002, The Journal of Neuroscience.

[14]  Kuo-Chen Chou,et al.  Molecular therapeutic target for type-2 diabetes. , 2004, Journal of proteome research.

[15]  J. Lindstrom,et al.  Neuronal nicotinic acetylcholine receptors. , 1996, Ion channels.

[16]  Kuo-Chen Chou,et al.  Prediction of the Tertiary Structure of the β-Secretase Zymogen☆ , 2002 .

[17]  E. Perry,et al.  α4 but Not α3 and α7 Nicotinic Acetylcholine Receptor Subunits Are Lost from the Temporal Cortex in Alzheimer's Disease , 1999 .

[18]  Gerhard Wagner,et al.  Solution Structure of the RAIDD CARD and Model for CARD/CARD Interaction in Caspase-2 and Caspase-9 Recruitment , 1998, Cell.

[19]  M. L. Connolly.  Solvent-accessible surfaces of proteins and nucleic acids. , 1983, Science.

[20]  M. L. Connolly.  Analytical molecular surface calculation , 1983 .

[21]  K. Chou,et al.  Prediction of the tertiary structure and substrate binding site of caspase‐8 , 1997, FEBS letters.

[22]  R. Papke,et al.  Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain nicotinic receptors, and brain penetration. , 2004, Molecular pharmacology.

[23]  K. Chou,et al.  Prediction of the tertiary structure of a caspase‐9/inhibitor complex , 2000, FEBS letters.

[24]  Hoau Yan Wang,et al.  Amyloid Peptide Aβ1‐42 Binds Selectively and with Picomolar Affinity to α7 Nicotinic Acetylcholine Receptors , 2000 .

[25]  Kuo-Chen Chou,et al.  Insights from modelling the 3D structure of the extracellular domain of alpha7 nicotinic acetylcholine receptor. , 2004, Biochemical and biophysical research communications.

[26]  Kuo-Chen Chou,et al.  The convergence‐divergence duality in lectin domains of selectin family and its implications , 1995, FEBS letters.

[27]  Hong Guo,et al.  Cooperative Hydrogen Bonding and Enzyme Catalysis. , 1998, Angewandte Chemie.

[28]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[29]  J. David Sweatt,et al.  β-Amyloid Peptide Activates α7 Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes* , 2002, The Journal of Biological Chemistry.

[30]  J K Lynch,et al.  Neuronal nicotinic acetylcholine receptors as targets for drug discovery. , 1997, Journal of medicinal chemistry.

[31]  Kuo-Chen Chou,et al.  Insights from Modeling the 3D Structure of DNA−CBF3b Complex , 2005 .

[32]  R Freedman,et al.  Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model. , 1996, Archives of general psychiatry.

[33]  I. Kuntz,et al.  Structure-Based Molecular Design , 1994 .

[34]  I. Kuntz.  Structure-Based Strategies for Drug Design and Discovery , 1992, Science.

[35]  Kuo-Chen Chou,et al.  Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS , 2003, Biochemical and Biophysical Research Communications.

[36]  Kuo-Chen Chou,et al.  Identification of the N‐terminal functional domains of Cdk5 by molecular truncation and computer modeling , 2002, Proteins.

[37]  Kuo-Chen Chou,et al.  Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. , 2004, Biochemical and biophysical research communications.

[38]  Junying Yuan,et al.  Solution Structure of BID, an Intracellular Amplifier of Apoptotic Signaling , 1999, Cell.